LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference Read more about LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference
LabCorp Prices $500 Million in 2.20% Senior Notes Due 2017 and $500 Million in 3.75% Senior Notes Due 2022 Read more about LabCorp Prices $500 Million in 2.20% Senior Notes Due 2017 and $500 Million in 3.75% Senior Notes Due 2022
LabCorp Announces Proposed Sale of Senior Notes Read more about LabCorp Announces Proposed Sale of Senior Notes
LabCorp Commends CDC for Revised HCV Testing Guidelines; Leading HCV Tests Available Through Monogram Biosciences, part of LabCorp’s Specialty Testing Group Read more about LabCorp Commends CDC for Revised HCV Testing Guidelines; Leading HCV Tests Available Through Monogram Biosciences, part of LabCorp’s Specialty Testing Group
LabCorp Completes and Publishes a Clinical Study for the Development and Validation of a PCR Assay for the Diagnosis of Bacterial Vaginosis Read more about LabCorp Completes and Publishes a Clinical Study for the Development and Validation of a PCR Assay for the Diagnosis of Bacterial Vaginosis
Laboratory Corporation of America® Holdings Announces 2012 Second Quarter Results Read more about Laboratory Corporation of America® Holdings Announces 2012 Second Quarter Results
LabCorp’s Acquisition of MEDTOX Clears Antitrust Approval Read more about LabCorp’s Acquisition of MEDTOX Clears Antitrust Approval
Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
